Intellectual Property

The Company has granted patents for TheraPEG™ in the EU (July 2009), US (September 2009), India (November 2009) and China (February 2010) and patents pending for HiPEG™ and CyPEG™. In addition, PolyTherics has filed a further five patent applications for specific PEGylation reagents and PEGylated products and for the use of specific polymer formulations for the solubilisation of insoluble molecules.

PolyTherics supports and develops its technologies through collaborative research and grant-funded projects and by funding PhD students to undertake relevant research.